Li Yang, Deng Ting, Tong Yi, Peng Shuling, Dong Bing, He Dacheng
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Mol Vis. 2008;14:2451-7. Epub 2008 Dec 29.
To report the clinical features and identification of two novel mutations in two Chinese pedigrees with autosomal dominant optic atrophy (ADOA).
Two families (F1 and F2) including ten affected members and nine unaffected family individuals were examined clinically. After informed consent was obtained, peripheral blood samples of all the participants were obtained, and genomic DNA was extracted. Linkage analysis was performed with two microsatellite markers around the OPA1 gene (D3S2305 and D3S3562) in family F1. The coding region (exon 1-28), including intron-exon boundary of the OPA1 gene, were screened in the 2 families by polymerase chain reaction (PCR) and direct DNA sequencing. Whenever substitutions were identified in a patient, single strand conformation polymorphism (SSCP) analysis was performed on all available family members and 100 normal controls. To characterize a splicing site mutation, RT-PCR of total RNA of leukocytes obtained from three patients and seven unaffected individuals of family F1 was performed with the specific primers.
The affected individuals all presented with bilateral visual failure and temporal or total pallor of the optic discs. Genotyping of family F1 revealed the linkage to the OPA1 gene on 3q28-29. After sequencing of OPA1 gene, a novel heterozygous splicing site mutation c.985 -2A>G in intron 9 was found in family F1. RT-PCR result showed the skipping of the exon 10 in the mutant transcript, which results in loss of 27 amino acids in the OPA1 protein. A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2.
Our findings expand the spectrum of OPA1 mutations and further established the role of OPA1 gene in Chinese patients with ADOA.
报告两个常染色体显性遗传性视神经萎缩(ADOA)中国家系的临床特征及两个新突变的鉴定。
对两个家系(F1和F2)进行临床检查,其中包括10名患病成员和9名未患病的家庭成员。在获得知情同意后,采集所有参与者的外周血样本并提取基因组DNA。对家系F1中OPA1基因周围的两个微卫星标记(D3S2305和D3S3562)进行连锁分析。通过聚合酶链反应(PCR)和直接DNA测序,对两个家系中OPA1基因的编码区(外显子1 - 28),包括内含子 - 外显子边界进行筛选。一旦在患者中鉴定出替代突变,就对所有可用的家庭成员和100名正常对照进行单链构象多态性(SSCP)分析。为了表征剪接位点突变,使用特异性引物对来自家系F1的三名患者和七名未患病个体的白细胞总RNA进行逆转录 - 聚合酶链反应(RT - PCR)。
患病个体均表现为双侧视力减退以及视盘颞侧或完全苍白。家系F1的基因分型显示与3q28 - 29上的OPA1基因连锁。对OPA1基因进行测序后,在家系F1中发现一个新的杂合剪接位点突变c.985 - 2A>G,位于内含子9中。RT - PCR结果显示突变转录本中外显子10跳跃,导致OPA1蛋白中27个氨基酸缺失。在家系F2中检测到一个新的杂合无义突变c.2197C>T(p.R733X)。
我们的发现扩展了OPA1突变谱,并进一步确定了OPA1基因在中国ADOA患者中的作用。